Rivaroxaban Failure in a Patient Taking Oxcarbazepine

Abstract

Get full access to this article

View all access options for this article.

References

Buller

Lensing

AWA

Prins

, et al. A dose ranging study evaluating once daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging study. Blood. 2008;112:2242-2247.

Martin

Thomas

Mahir

, et al. Direct oral anticoagulant concentrations in obese and high body weight patients: a cohort study. Thromb Haemost. Published online August 30, 2020. doi:10.1055/s-0040-1715834

Rivaroxaban/Oxcarbazepine interaction (Lexi-Drugs). Lexi-Comp Inc; 2020.

Xarelto. Package insert. Janssen Pharmaceuticals Inc; 2020.

Serra

Li Calzi

Coruzzi

Left atrial appendage thrombosis during therapy with rivaroxaban in elective cardioversion for permanent atrial fibrillation. Clin Pract. 2015;5:788. doi:10.4081/cp.2015.788

Galgani

Palleria

Iannone

, et al. Pharmacokinetic interactions of clinical interest between direct oral anticoagulants and antiepileptic drugs. Front Neurol. 2018;9:1067. Published correction appears in Front Neurol. 2020;10:1381.